1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hyperthyroidism Medications Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hyperthyroidism Medications by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hyperthyroidism Medications by Country/Region, 2018, 2022 & 2029
2.2 Hyperthyroidism Medications Segment by Type
2.2.1 Methimazole
2.2.2 Propylthiouracil
2.2.3 Other
2.3 Hyperthyroidism Medications Sales by Type
2.3.1 Global Hyperthyroidism Medications Sales Market Share by Type (2018-2023)
2.3.2 Global Hyperthyroidism Medications Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hyperthyroidism Medications Sale Price by Type (2018-2023)
2.4 Hyperthyroidism Medications Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Hyperthyroidism Medications Sales by Application
2.5.1 Global Hyperthyroidism Medications Sale Market Share by Application (2018-2023)
2.5.2 Global Hyperthyroidism Medications Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hyperthyroidism Medications Sale Price by Application (2018-2023)
3 Global Hyperthyroidism Medications by Company
3.1 Global Hyperthyroidism Medications Breakdown Data by Company
3.1.1 Global Hyperthyroidism Medications Annual Sales by Company (2018-2023)
3.1.2 Global Hyperthyroidism Medications Sales Market Share by Company (2018-2023)
3.2 Global Hyperthyroidism Medications Annual Revenue by Company (2018-2023)
3.2.1 Global Hyperthyroidism Medications Revenue by Company (2018-2023)
3.2.2 Global Hyperthyroidism Medications Revenue Market Share by Company (2018-2023)
3.3 Global Hyperthyroidism Medications Sale Price by Company
3.4 Key Manufacturers Hyperthyroidism Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyperthyroidism Medications Product Location Distribution
3.4.2 Players Hyperthyroidism Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hyperthyroidism Medications by Geographic Region
4.1 World Historic Hyperthyroidism Medications Market Size by Geographic Region (2018-2023)
4.1.1 Global Hyperthyroidism Medications Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hyperthyroidism Medications Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hyperthyroidism Medications Market Size by Country/Region (2018-2023)
4.2.1 Global Hyperthyroidism Medications Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hyperthyroidism Medications Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hyperthyroidism Medications Sales Growth
4.4 APAC Hyperthyroidism Medications Sales Growth
4.5 Europe Hyperthyroidism Medications Sales Growth
4.6 Middle East & Africa Hyperthyroidism Medications Sales Growth
5 Americas
5.1 Americas Hyperthyroidism Medications Sales by Country
5.1.1 Americas Hyperthyroidism Medications Sales by Country (2018-2023)
5.1.2 Americas Hyperthyroidism Medications Revenue by Country (2018-2023)
5.2 Americas Hyperthyroidism Medications Sales by Type
5.3 Americas Hyperthyroidism Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyperthyroidism Medications Sales by Region
6.1.1 APAC Hyperthyroidism Medications Sales by Region (2018-2023)
6.1.2 APAC Hyperthyroidism Medications Revenue by Region (2018-2023)
6.2 APAC Hyperthyroidism Medications Sales by Type
6.3 APAC Hyperthyroidism Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hyperthyroidism Medications by Country
7.1.1 Europe Hyperthyroidism Medications Sales by Country (2018-2023)
7.1.2 Europe Hyperthyroidism Medications Revenue by Country (2018-2023)
7.2 Europe Hyperthyroidism Medications Sales by Type
7.3 Europe Hyperthyroidism Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hyperthyroidism Medications by Country
8.1.1 Middle East & Africa Hyperthyroidism Medications Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hyperthyroidism Medications Revenue by Country (2018-2023)
8.2 Middle East & Africa Hyperthyroidism Medications Sales by Type
8.3 Middle East & Africa Hyperthyroidism Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyperthyroidism Medications
10.3 Manufacturing Process Analysis of Hyperthyroidism Medications
10.4 Industry Chain Structure of Hyperthyroidism Medications
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyperthyroidism Medications Distributors
11.3 Hyperthyroidism Medications Customer
12 World Forecast Review for Hyperthyroidism Medications by Geographic Region
12.1 Global Hyperthyroidism Medications Market Size Forecast by Region
12.1.1 Global Hyperthyroidism Medications Forecast by Region (2024-2029)
12.1.2 Global Hyperthyroidism Medications Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hyperthyroidism Medications Forecast by Type
12.7 Global Hyperthyroidism Medications Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Hyperthyroidism Medications Product Portfolios and Specifications
13.1.3 Merck Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Herbrand PharmaChemicals
13.2.1 Herbrand PharmaChemicals Company Information
13.2.2 Herbrand PharmaChemicals Hyperthyroidism Medications Product Portfolios and Specifications
13.2.3 Herbrand PharmaChemicals Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Herbrand PharmaChemicals Main Business Overview
13.2.5 Herbrand PharmaChemicals Latest Developments
13.3 Shanghai Zhaohui Pharmaceutical
13.3.1 Shanghai Zhaohui Pharmaceutical Company Information
13.3.2 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
13.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shanghai Zhaohui Pharmaceutical Main Business Overview
13.3.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13.4 Beijing Yanjing Pharmaceutical
13.4.1 Beijing Yanjing Pharmaceutical Company Information
13.4.2 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
13.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Yanjing Pharmaceutical Main Business Overview
13.4.5 Beijing Yanjing Pharmaceutical Latest Developments
13.5 Jinghua Pharmaceutical Group
13.5.1 Jinghua Pharmaceutical Group Company Information
13.5.2 Jinghua Pharmaceutical Group Hyperthyroidism Medications Product Portfolios and Specifications
13.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jinghua Pharmaceutical Group Main Business Overview
13.5.5 Jinghua Pharmaceutical Group Latest Developments
13.6 Guangzhou Kanghe Pharmaceutical
13.6.1 Guangzhou Kanghe Pharmaceutical Company Information
13.6.2 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
13.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Guangzhou Kanghe Pharmaceutical Main Business Overview
13.6.5 Guangzhou Kanghe Pharmaceutical Latest Developments
13.7 Zigong Honghe Pharmaceutical
13.7.1 Zigong Honghe Pharmaceutical Company Information
13.7.2 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
13.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zigong Honghe Pharmaceutical Main Business Overview
13.7.5 Zigong Honghe Pharmaceutical Latest Developments
13.8 Guangdong Huanan Pharmaceutical
13.8.1 Guangdong Huanan Pharmaceutical Company Information
13.8.2 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
13.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Guangdong Huanan Pharmaceutical Main Business Overview
13.8.5 Guangdong Huanan Pharmaceutical Latest Developments
13.9 Zibo Wankang Pharmaceutical Chemical
13.9.1 Zibo Wankang Pharmaceutical Chemical Company Information
13.9.2 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product Portfolios and Specifications
13.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zibo Wankang Pharmaceutical Chemical Main Business Overview
13.9.5 Zibo Wankang Pharmaceutical Chemical Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Hyperthyroidism Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hyperthyroidism Medications Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hyperthyroidism Medications Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Methimazole
Table 4. Major Players of Propylthiouracil
Table 5. Major Players of Other
Table 6. Global Hyperthyroidism Medications Sales by Type (2018-2023) & (K Units)
Table 7. Global Hyperthyroidism Medications Sales Market Share by Type (2018-2023)
Table 8. Global Hyperthyroidism Medications Revenue by Type (2018-2023) & ($ million)
Table 9. Global Hyperthyroidism Medications Revenue Market Share by Type (2018-2023)
Table 10. Global Hyperthyroidism Medications Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Hyperthyroidism Medications Sales by Application (2018-2023) & (K Units)
Table 12. Global Hyperthyroidism Medications Sales Market Share by Application (2018-2023)
Table 13. Global Hyperthyroidism Medications Revenue by Application (2018-2023)
Table 14. Global Hyperthyroidism Medications Revenue Market Share by Application (2018-2023)
Table 15. Global Hyperthyroidism Medications Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Hyperthyroidism Medications Sales by Company (2018-2023) & (K Units)
Table 17. Global Hyperthyroidism Medications Sales Market Share by Company (2018-2023)
Table 18. Global Hyperthyroidism Medications Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Hyperthyroidism Medications Revenue Market Share by Company (2018-2023)
Table 20. Global Hyperthyroidism Medications Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Hyperthyroidism Medications Producing Area Distribution and Sales Area
Table 22. Players Hyperthyroidism Medications Products Offered
Table 23. Hyperthyroidism Medications Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Hyperthyroidism Medications Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Hyperthyroidism Medications Sales Market Share Geographic Region (2018-2023)
Table 28. Global Hyperthyroidism Medications Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Hyperthyroidism Medications Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Hyperthyroidism Medications Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Hyperthyroidism Medications Sales Market Share by Country/Region (2018-2023)
Table 32. Global Hyperthyroidism Medications Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Hyperthyroidism Medications Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Hyperthyroidism Medications Sales by Country (2018-2023) & (K Units)
Table 35. Americas Hyperthyroidism Medications Sales Market Share by Country (2018-2023)
Table 36. Americas Hyperthyroidism Medications Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Hyperthyroidism Medications Revenue Market Share by Country (2018-2023)
Table 38. Americas Hyperthyroidism Medications Sales by Type (2018-2023) & (K Units)
Table 39. Americas Hyperthyroidism Medications Sales by Application (2018-2023) & (K Units)
Table 40. APAC Hyperthyroidism Medications Sales by Region (2018-2023) & (K Units)
Table 41. APAC Hyperthyroidism Medications Sales Market Share by Region (2018-2023)
Table 42. APAC Hyperthyroidism Medications Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Hyperthyroidism Medications Revenue Market Share by Region (2018-2023)
Table 44. APAC Hyperthyroidism Medications Sales by Type (2018-2023) & (K Units)
Table 45. APAC Hyperthyroidism Medications Sales by Application (2018-2023) & (K Units)
Table 46. Europe Hyperthyroidism Medications Sales by Country (2018-2023) & (K Units)
Table 47. Europe Hyperthyroidism Medications Sales Market Share by Country (2018-2023)
Table 48. Europe Hyperthyroidism Medications Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Hyperthyroidism Medications Revenue Market Share by Country (2018-2023)
Table 50. Europe Hyperthyroidism Medications Sales by Type (2018-2023) & (K Units)
Table 51. Europe Hyperthyroidism Medications Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Hyperthyroidism Medications Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Hyperthyroidism Medications Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Hyperthyroidism Medications Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Hyperthyroidism Medications Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hyperthyroidism Medications Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Hyperthyroidism Medications Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Hyperthyroidism Medications
Table 59. Key Market Challenges & Risks of Hyperthyroidism Medications
Table 60. Key Industry Trends of Hyperthyroidism Medications
Table 61. Hyperthyroidism Medications Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Hyperthyroidism Medications Distributors List
Table 64. Hyperthyroidism Medications Customer List
Table 65. Global Hyperthyroidism Medications Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Hyperthyroidism Medications Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Hyperthyroidism Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Hyperthyroidism Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Hyperthyroidism Medications Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Hyperthyroidism Medications Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Hyperthyroidism Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Hyperthyroidism Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Hyperthyroidism Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Hyperthyroidism Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Hyperthyroidism Medications Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Hyperthyroidism Medications Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Hyperthyroidism Medications Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Hyperthyroidism Medications Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Hyperthyroidism Medications Product Portfolios and Specifications
Table 81. Merck Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Herbrand PharmaChemicals Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 85. Herbrand PharmaChemicals Hyperthyroidism Medications Product Portfolios and Specifications
Table 86. Herbrand PharmaChemicals Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Herbrand PharmaChemicals Main Business
Table 88. Herbrand PharmaChemicals Latest Developments
Table 89. Shanghai Zhaohui Pharmaceutical Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 90. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
Table 91. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Shanghai Zhaohui Pharmaceutical Main Business
Table 93. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 94. Beijing Yanjing Pharmaceutical Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 95. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
Table 96. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Beijing Yanjing Pharmaceutical Main Business
Table 98. Beijing Yanjing Pharmaceutical Latest Developments
Table 99. Jinghua Pharmaceutical Group Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 100. Jinghua Pharmaceutical Group Hyperthyroidism Medications Product Portfolios and Specifications
Table 101. Jinghua Pharmaceutical Group Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Jinghua Pharmaceutical Group Main Business
Table 103. Jinghua Pharmaceutical Group Latest Developments
Table 104. Guangzhou Kanghe Pharmaceutical Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 105. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
Table 106. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Guangzhou Kanghe Pharmaceutical Main Business
Table 108. Guangzhou Kanghe Pharmaceutical Latest Developments
Table 109. Zigong Honghe Pharmaceutical Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 110. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
Table 111. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Zigong Honghe Pharmaceutical Main Business
Table 113. Zigong Honghe Pharmaceutical Latest Developments
Table 114. Guangdong Huanan Pharmaceutical Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 115. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
Table 116. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Guangdong Huanan Pharmaceutical Main Business
Table 118. Guangdong Huanan Pharmaceutical Latest Developments
Table 119. Zibo Wankang Pharmaceutical Chemical Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 120. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product Portfolios and Specifications
Table 121. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Zibo Wankang Pharmaceutical Chemical Main Business
Table 123. Zibo Wankang Pharmaceutical Chemical Latest Developments
Table 124. Qilu Pharmaceutical Basic Information, Hyperthyroidism Medications Manufacturing Base, Sales Area and Its Competitors
Table 125. Qilu Pharmaceutical Hyperthyroidism Medications Product Portfolios and Specifications
Table 126. Qilu Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Qilu Pharmaceutical Main Business
Table 128. Qilu Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Hyperthyroidism Medications
Figure 2. Hyperthyroidism Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyperthyroidism Medications Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hyperthyroidism Medications Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hyperthyroidism Medications Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Methimazole
Figure 10. Product Picture of Propylthiouracil
Figure 11. Product Picture of Other
Figure 12. Global Hyperthyroidism Medications Sales Market Share by Type in 2022
Figure 13. Global Hyperthyroidism Medications Revenue Market Share by Type (2018-2023)
Figure 14. Hyperthyroidism Medications Consumed in Hospital
Figure 15. Global Hyperthyroidism Medications Market: Hospital (2018-2023) & (K Units)
Figure 16. Hyperthyroidism Medications Consumed in Clinic
Figure 17. Global Hyperthyroidism Medications Market: Clinic (2018-2023) & (K Units)
Figure 18. Hyperthyroidism Medications Consumed in Other
Figure 19. Global Hyperthyroidism Medications Market: Other (2018-2023) & (K Units)
Figure 20. Global Hyperthyroidism Medications Sales Market Share by Application (2022)
Figure 21. Global Hyperthyroidism Medications Revenue Market Share by Application in 2022
Figure 22. Hyperthyroidism Medications Sales Market by Company in 2022 (K Units)
Figure 23. Global Hyperthyroidism Medications Sales Market Share by Company in 2022
Figure 24. Hyperthyroidism Medications Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Hyperthyroidism Medications Revenue Market Share by Company in 2022
Figure 26. Global Hyperthyroidism Medications Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Hyperthyroidism Medications Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Hyperthyroidism Medications Sales 2018-2023 (K Units)
Figure 29. Americas Hyperthyroidism Medications Revenue 2018-2023 ($ Millions)
Figure 30. APAC Hyperthyroidism Medications Sales 2018-2023 (K Units)
Figure 31. APAC Hyperthyroidism Medications Revenue 2018-2023 ($ Millions)
Figure 32. Europe Hyperthyroidism Medications Sales 2018-2023 (K Units)
Figure 33. Europe Hyperthyroidism Medications Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Hyperthyroidism Medications Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Hyperthyroidism Medications Revenue 2018-2023 ($ Millions)
Figure 36. Americas Hyperthyroidism Medications Sales Market Share by Country in 2022
Figure 37. Americas Hyperthyroidism Medications Revenue Market Share by Country in 2022
Figure 38. Americas Hyperthyroidism Medications Sales Market Share by Type (2018-2023)
Figure 39. Americas Hyperthyroidism Medications Sales Market Share by Application (2018-2023)
Figure 40. United States Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Hyperthyroidism Medications Sales Market Share by Region in 2022
Figure 45. APAC Hyperthyroidism Medications Revenue Market Share by Regions in 2022
Figure 46. APAC Hyperthyroidism Medications Sales Market Share by Type (2018-2023)
Figure 47. APAC Hyperthyroidism Medications Sales Market Share by Application (2018-2023)
Figure 48. China Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Hyperthyroidism Medications Sales Market Share by Country in 2022
Figure 56. Europe Hyperthyroidism Medications Revenue Market Share by Country in 2022
Figure 57. Europe Hyperthyroidism Medications Sales Market Share by Type (2018-2023)
Figure 58. Europe Hyperthyroidism Medications Sales Market Share by Application (2018-2023)
Figure 59. Germany Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Hyperthyroidism Medications Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Hyperthyroidism Medications Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Hyperthyroidism Medications Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Hyperthyroidism Medications Sales Market Share by Application (2018-2023)
Figure 68. Egypt Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Hyperthyroidism Medications Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Hyperthyroidism Medications in 2022
Figure 74. Manufacturing Process Analysis of Hyperthyroidism Medications
Figure 75. Industry Chain Structure of Hyperthyroidism Medications
Figure 76. Channels of Distribution
Figure 77. Global Hyperthyroidism Medications Sales Market Forecast by Region (2024-2029)
Figure 78. Global Hyperthyroidism Medications Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Hyperthyroidism Medications Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Hyperthyroidism Medications Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Hyperthyroidism Medications Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Hyperthyroidism Medications Revenue Market Share Forecast by Application (2024-2029)

※参考情報 甲状腺機能亢進症は、甲状腺ホルモンが過剰に分泌される状態であり、体の代謝を異常に促進させる病気です。これにより、体重減少、動悸、過度の発汗、神経過敏、疲労感、睡眠障害など、さまざまな症状が現れます。甲状腺機能亢進症の治療には、主に薬物療法が用いられます。 甲状腺機能亢進症の治療薬は、甲状腺ホルモンの合成を妨げたり、ホルモンの作用を遮断したりすることで、甲状腺ホルモンの過剰状態を改善することを目的としています。これらの薬物は、大きく分けて抗甲状腺薬、β遮断薬、放射性ヨウ素、ステロイドなどに分類されます。それぞれの特徴や用途について詳しく見ていきましょう。 抗甲状腺薬は、甲状腺におけるホルモン合成を抑制することで、ホルモンの分泌を減少させる作用を持っています。代表的な薬剤としては、メチマゾールとプロピルチオウラシルがあります。メチマゾールは、甲状腺ホルモンの合成を強力に抑制し、特にグレーブス病（バセドウ病）に多く使用されます。一方、プロピルチオウラシルは、主に妊娠中や授乳中の女性に選択されることが多く、胎児への影響が少ないとされています。 これらの抗甲状腺薬は通常、経口で投与され、効果が現れるまでに数週間かかることが一般的です。また、治療中は定期的に血液検査を行い、甲状腺ホルモンの値をモニタリングすることが重要です。副作用としては、白血球の減少や肝機能障害などが報告されており、注意深い管理が必要です。 次に、β遮断薬は主に症状の緩和を目的として使用されます。甲状腺機能亢進症の患者は、心拍数が増加し、動悸や不安感を感じることが多いため、これらの症状を軽減するために用いられます。プロプラノロールなどのβ遮断薬は、心拍数を下げると同時に、掻痒感や発汗などの自律神経系の亢進に関連する症状を改善します。β遮断薬は、抗甲状腺薬と併用されることが多く、短期間の応急措置としても使用されます。 放射性ヨウ素療法は、甲状腺機能亢進症の治療において重要な選択肢の一つです。放射性ヨウ素を含む薬剤を経口摂取すると、体内で甲状腺がそれを取り込むことで、甲状腺細胞が破壊され、ホルモンの分泌が減少します。この治療法は、特に重症のグレーブス病や再発する甲状腺機能亢進症に対して効果的です。ただし、放射性ヨウ素療法後は、甲状腺機能が低下し、甲状腺機能低下症（甲状腺のホルモンが不足する状態）を引き起こす可能性があるため、定期的なフォローアップが必須です。また、この治療法は妊娠中の女性には適用されません。 ステロイドは、自己免疫性の原因による甲状腺機能亢進症において、炎症を抑えて病状を改善することを目的として使用されることがあります。特に、甲状腺を含む自己免疫疾患においては、免疫反応を抑制することが有用です。しかし、長期にわたるステロイド療法は副作用が多いため、注意が必要です。 近年では、甲状腺機能亢進症の治療において新たな技術や治療法の開発も進められています。例えば、分子標的治療薬が研究されており、これによりホルモン合成にかかわる特定の経路を阻害することで、治療の選択肢が広がる可能性があります。また、遺伝子治療や免疫療法などの先端医療も、今後の治療法の選択肢として注目されている分野です。 甲状腺機能亢進症の治療においては、患者の年齢や性別、症状の程度、合併症の有無、個々の治療歴やライフスタイルに応じた個別化が求められます。治療にあたっては、医師と患者との密なコミュニケーションを行いながら、最適な治療方針を決定することが重要です。さらに、生活習慣や食事、ストレス管理なども治療の一環として考慮されるべき要素です。 結論として、甲状腺機能亢進症の治療薬は多岐にわたり、それぞれに特有の作用や副作用があります。抗甲状腺薬やβ遮断薬が主要な治療手段として広く使用されている一方で、放射性ヨウ素療法や新たな治療法も債務として有用です。今後も研究が進むことで、より効果的で安全な治療薬の開発が期待されており、甲状腺機能亢進症に苦しむ多くの患者にとって希望となることでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer